Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities Growth (1y) (2011 - 2025)
Ironwood Pharmaceuticals (IRWD) Cash from Investing Activities Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -308.05% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -41.51% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -139.86% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 129.18% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.71% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -366.90% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | -96.43% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 676.53 Mn | 597.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 87.50% |
| Jun 30, 2025 | 96.55% |
| Mar 31, 2025 | 54.41% |
| Sep 30, 2024 | 99.93% |
| Jun 30, 2024 | 99.99% |
| Mar 31, 2024 | -423.08% |
| Dec 31, 2023 | -15,611.11% |
| Sep 30, 2023 | -34,180.30% |
| Jun 30, 2023 | -1,135,686.36% |
| Mar 31, 2023 | -44.44% |
| Dec 31, 2022 | 121.09% |
| Dec 31, 2021 | -357.14% |
| Dec 31, 2020 | 98.95% |
| Jun 30, 2020 | 84.52% |
| Mar 31, 2020 | -215.41% |
| Dec 31, 2019 | -115.22% |
| Sep 30, 2019 | -158.26% |
| Jun 30, 2019 | -117.11% |
| Mar 31, 2019 | -97.21% |
| Dec 31, 2018 | 153.90% |